Phase 2 Hepatitis C Virus Infection Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Completed
Phase 2
A study of the safety of 3 months treatment with BIT225, in combination with pegylated interferon and ribavirin, in patients with chronic hepatitis C infection, compared to pegylated interferon and ribavirin alone, including measurement of the concentration of BIT225 in the blood and antiviral activity.
Hepatitis C Virus Infection
Biotron Limited60 enrolled1 locationACTRN12613001296729
Completed
Phase 2
A study of the safety of BIT225 in combination with pegylated interferon and ribavirin in patients with hepatitis C virus and human immunodeficiency virus co-infection, who are naive to treatment with pegylated interferon and ribavirin, and whose HIV is currently well controlled by standard antiretroviral therapy.
Hepatitis C Virus infection in patients co-infected with human immunodeficiency virus-1
Biotron Limited12 enrolled1 locationACTRN12612001189819
Completed
Phase 2
A study of the safety of combining BIT225 with pegylated interferon and ribavirin, in patients with hepatitis C virus infection, including measurement of the concentration and distribution of BIT225 in the body and antiviral activity.
Hepatitis C Virus Infection
Biotron Limited24 enrolled1 locationACTRN12612000828820